Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm.
Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients.
Propentofylline treatment on open field behavior in rats with focal ethidium bromide-induced demyelination in the ventral surface of the brainstem.
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis.
Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.
Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards.
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient.
IFNγ Influences Type I Interferon Response and Susceptibility to Theiler's Virus-Induced Demyelinating Disease.
Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis.
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.
Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Claudin Proteins And Neuronal Function.
The innate immune system in demyelinating disease.
Purkinje cell dysfunction and delayed death in plasma membrane calcium ATPase 2-heterozygous mice.
Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis.
The Blood-Brain Barrier in Multiple Sclerosis: MicroRNAs as Key Regulators.
Applications of coherent Raman scattering microscopies to clinical and biological studies.
Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
Cardiopulmonary fitness is related to disease severity in multiple sclerosis.
Subacute sclerosing panencephalitis presenting as neuromyelitis optica.
The radiologically isolated syndrome dilemma: just an incidental radiological finding or presymptomatic multiple sclerosis?
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
445
446
447
448
449
450
451
452
453
…
next ›
last »